Latest filing published 11 Aug 2020 for Aequus Pharmaceuticals Inc., €32k.
No signal scores available.
All filings by Stuart William Fowler on record concern Aequus Pharmaceuticals Inc. Between 1 February 2020 and 6 August 2020, the trades on record add up to 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 11 August 2020: a transaction of €32k, in Aequus Pharmaceuticals Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations